22157.jpg
Drug Overdose Treatments Pipeline Report 2021: Drugs in Development by Sstage of Development, Drug Target, Mechanism of Action, Route of administration (RoA) and Molecule Type
August 23, 2021 05:23 ET | Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Drug Overdose - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. Drug Overdose - Drugs In Development, 2021,...
American College of Medical Toxicology Reports Data on Adverse Effects and Toxicity from Unapproved Use of Ivermectin for the Prevention or Treatment of COVID-19
August 20, 2021 11:49 ET | American College of Medical Toxicology
Phoenix, AZ, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology’s Toxicology Investigators Consortium (ToxIC) has received several reports of patients who became ill from...
22157.jpg
Global Contract Research Organization Services Market (2021 to 2026) - Rising Demand for Specialized Testing Services Among End-users Presents Opportunities
August 03, 2021 09:23 ET | Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Laboratory), Therapeutic Area (Oncology, Infectious...
22157.jpg
Outlook on the COVID-19 Diagnostics Global Market to 2025 - Assay Volumes and Market Size Outlook
July 05, 2021 06:23 ET | Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Diagnostics: Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country - Assay Volumes and Market Size Outlook to...
Inotiv_Logo_CMYK.png
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity
May 27, 2021 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., May 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
22157.jpg
Global $1.88 Billion Quantitative Structure-Activity Relationship Market to 2027: Increasing Adoption of Modeling Tools in Drug Discovery & Economic Burden of Drug Discovery
May 05, 2021 04:18 ET | Research and Markets
Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Quantitative Structure-Activity Relationship Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application; Industry, and Geography"...
22157.jpg
Global Toxicology Drug Screening Market 2020-2028: What Issues will Matter in 2021 and Beyond
April 20, 2021 04:03 ET | Research and Markets
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Toxicology Drug Screening Market Research and Outlook, 2020 - Trends, Growth Opportunities and Forecasts to 2028" report has been added to...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations
April 19, 2021 07:00 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 19, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
22157.jpg
The Worldwide In Vivo Toxicology Industry is Expected to Reach $6.6 Billion by 2025 at a CAGR of 5.5% from 2020
April 08, 2021 06:43 ET | Research and Markets
Dublin, April 08, 2021 (GLOBE NEWSWIRE) -- The "In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic,...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Partnership with PhoenixBio Co., Ltd. to Expand Discovery Pharmacology Offering
April 06, 2021 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 06, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research...